Absolute Antibody was founded in 2012 with a vision to make recombinant antibody technology accessible to all. We offer antibody sequencing, engineering and recombinant production as royalty-free custom services, as well as a unique reagents catalog of recombinant antibodies and Fc Fusion proteins, engineered into new and useful formats. Our customers include leading pharmaceutical, biotechnology and diagnostics companies, as well as academic researchers worldwide. Our international customer base is served by our ISO 9001:2015-certified antibody manufacturing facility in Northeast England and additional offices in Boston in the United States and Amsterdam in the Netherlands. In 2022, we became part of Absolute Biotech, a new company that unites multiple life science brands into one organization specializing in antibody reagents and services. Learn more at absolutebiotech.com.
Looking for a particular Absolute Antibody employee's phone or email?
The Absolute Antibody annual revenue was $18.6 million in 2026.
Michael Fiebig is the Chief Scientific Officer of Absolute Antibody.
19 people are employed at Absolute Antibody.
The NAICS codes for Absolute Antibody are [541714, 54, 541, 54171, 5417].
The SIC codes for Absolute Antibody are [87, 873].